Knowledge survey to assess the effectiveness of educational materials among patients prescribed LEMTRADA® (alemtuzumab)

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Cross-sectional

Study drug and medical condition

• Name of medicine:
  LEMTRADA

Population studied

• Short description of the study population:
  Patients prescribed Lemtrada.; Inclusion criteria; • Patient has been diagnosed with Multiple Sclerosis (MS); • Patient has been prescribed at least one dose of Lemtrada; • Patient supplies informed consent by ticking a box on the website.; Exclusion criteria; • Patient completed the survey in Wave 1; • Patient has not been prescribed Lemtrada.
• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Special population of interest:
  Other
• Special population of interest, other:
  Multiple sclerosis patients
• Estimated number of subjects:
  0

Study design details

• Main study objective:
  The objective of the survey is to assess descriptively the knowledge of treated patients about the key educational messages concerning autoimmune conditions and serious infections, and adherence to monitoring, to ensure the safe use of LEMTRADA.
• Outcomes:
  Awareness of patient educational materials, knowledge about SAEs and signs and symptoms related to LEMTRADA, and knowledge of risk minimization activities. Comparisons of patient knowledge at the country level.
• Data analysis plan:
  Descriptive analyses including the number and percentage of patients that demonstrated knowledge and awareness of educational materials.

Documents

Study results

riskmgtsystem-patient-survey-report